HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus.

Abstract
Marek's disease virus (MDV) is a herpesvirus that induces T lymphomas in chickens. The aim of this study was to assess the role of the macrophage activator chicken myelomonocytic growth factor (cMGF) in controlling MDV infection. B13/B13 chickens, which are highly susceptible to MD, were either treated with cMGF delivered via a live fowlpox virus (fp/cMGF) or treated with the parent vector (fp/M3) or were left as untreated controls. Seven days later, when challenged with the very virulent RB-1B strain of MDV, the spleens of chickens treated with fp/cMGF showed increased expression of the inducible nitric oxide synthase (iNOS) gene compared to those of control chickens and fp/M3-treated chickens. Increased iNOS gene expression was also accompanied by greater induction of gamma interferon and macrophage inflammatory protein (K203) gene expression, both possible activators of iNOS. fp/cMGF treatment also increased the number of monocytes and systemic NO production in contrast to fp/M3 treatment. Even though cMGF treatment was unable to prevent death for the chickens, it did prolong their survival time, and viremia and tumor incidence were greatly reduced. In addition, cMGF treatment improved the partial protection induced by vaccination with HVT (herpesvirus isolated from turkeys) against RB-1B, preventing 100% mortality (versus 66% with vaccination alone) and greatly reducing tumor development. Treatment with fp/M3 did not have such effects. These results suggest that cMGF may play multiple roles in protection against MD. First, it may enhance the innate immune response by increasing the number and activity of monocytes and macrophages, resulting in increased NO production. Second, it may enhance the acquired immune response, indicated by its ability to enhance vaccine efficacy.
AuthorsAouatef Djeraba, Eugène Musset, John W Lowenthal, David B Boyle, Anne-Marie Chaussé, Michele Péloille, Pascale Quéré
JournalJournal of virology (J Virol) Vol. 76 Issue 3 Pg. 1062-70 (Feb 2002) ISSN: 0022-538X [Print] United States
PMID11773382 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Avian Proteins
  • Cytokines
  • Growth Substances
  • Intercellular Signaling Peptides and Proteins
  • MGF protein, chicken
  • Macrophage Inflammatory Proteins
  • Nitrates
  • Interferon-gamma
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
Topics
  • Animals
  • Avian Proteins
  • Chickens
  • Cytokines (genetics)
  • Gene Expression
  • Growth Substances (administration & dosage, genetics, immunology)
  • Herpesvirus 2, Gallid (genetics, immunology, physiology)
  • Intercellular Signaling Peptides and Proteins
  • Interferon-gamma (genetics)
  • Macrophage Inflammatory Proteins (genetics)
  • Marek Disease (blood, immunology, prevention & control, virology)
  • Monocytes (cytology)
  • Nitrates (metabolism)
  • Nitric Oxide Synthase (genetics)
  • Nitric Oxide Synthase Type II
  • Spleen (immunology)
  • Time Factors
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: